We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+7.8%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$484B
AUM Growth
+$29.1B
Cap. Flow
-$16.6B
Cap. Flow %
-3.43%
Top 10 Hldgs %
36.47%
Holding
15,826
New
1,205
Increased
5,575
Reduced
7,223
Closed
1,563

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$545M
2
DXCM icon
DexCom
DXCM
+$457M
3
T icon
AT&T
T
+$431M
4
PANW icon
Palo Alto Networks
PANW
+$416M
5
HUM icon
Humana
HUM
+$394M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Healthcare 2.92%
3 Consumer Discretionary 1.99%
4 Financials 1.93%
5 Industrials 1.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRHC
13001
PUT
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$12.4K ﹤0.01%
1,500
-1,100
-42% -$6.58K
ATHX
13002
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$12.4K ﹤0.01%
14,200
-2,408
-14% -$2.17K
AURA icon
13003
CALL
Aura Biosciences
AURA
$795M
$12.3K ﹤0.01%
+1,000
New +$10.7K
AURA icon
13004
PUT
Aura Biosciences
AURA
$795M
$12.3K ﹤0.01%
+1,000
New +$10.7K
CCC
13005
CALL
CCC Intelligent Solutions
CCC
$4.11B
$12.3K ﹤0.01%
1,100
-1,900
-63% -$18.7K
DLNG icon
13006
CALL
Dynagas LNG Partners
DLNG
$140M
$12.3K ﹤0.01%
4,900
-23,700
-83% -$62.2K
GRSD
13007
PUT
Grandstand Limited Ordinary Shares
GRSD
$80.4M
$12.3K ﹤0.01%
+1,200
New +$12K
DIHP icon
13008
CALL
Dimensional International High Profitability ETF
DIHP
$6.59B
$12.2K ﹤0.01%
+500
New +$12.2K
SSY
13009
DELISTED
SunLink Health Systems
SSY
$12.2K ﹤0.01%
+13,416
New +$13.2K
IBIO icon
13010
iBio
IBIO
$71M
$12.2K ﹤0.01%
1,001
+624
+166% +$11.8K
OMIC
13011
PUT
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$12.2K ﹤0.01%
490
+477
+3,669% +$14K
PRAX icon
13012
CALL
Praxis Precision Medicines
PRAX
$10.2B
$12.2K ﹤0.01%
707
+94
+15% +$1.44K
ISSC icon
13013
CALL
Innovative Solutions & Support
ISSC
$412M
$12.2K ﹤0.01%
1,700
-3,200
-65% -$22K
AGRO icon
13014
PUT
Adecoagro
AGRO
$1.29B
$12.2K ﹤0.01%
1,300
-99,100
-99% -$877K
TIXT
13015
PUT
DELISTED
TELUS International
TIXT
$12.1K ﹤0.01%
+800
New +$13.9K
NUVB.WS
13016
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$12.1K ﹤0.01%
73,358
-1,700
-2% -$266
PHXM
13017
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$12.1K ﹤0.01%
1,661
+580
+54% +$5.1K
WIMI
13018
CALL
WiMi Hologram Cloud
WIMI
$25M
$12.1K ﹤0.01%
1,100
-100
-8% -$1.01K
ACER
13019
PUT
DELISTED
Acer Therapeutics Inc
ACER
$12.1K ﹤0.01%
13,100
-13,400
-51% -$11.9K
HVT icon
13020
PUT
Haverty Furniture Companies
HVT
$449M
$12.1K ﹤0.01%
400
-2,300
-85% -$65.8K
STXS icon
13021
CALL
Stereotaxis
STXS
$137M
$12.1K ﹤0.01%
7,900
+1,400
+22% +$2.6K
BHR
13022
PUT
Braemar Hotels & Resorts
BHR
$139M
$12.1K ﹤0.01%
3,000
-5,600
-65% -$22.1K
RSVR
13023
CALL
Reservoir Media
RSVR
$657M
$12K ﹤0.01%
+2,000
New +$12.6K
CEI
13024
CALL
DELISTED
Camber Energy, Inc
CEI
$12K ﹤0.01%
18,876
-9,822
-34% -$11.7K
GOSS icon
13025
PUT
Gossamer Bio
GOSS
$75.4M
$12K ﹤0.01%
10,000
-31,300
-76% -$39K

Similar funds

Citadel Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Citadel Advisors held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Citadel Advisors withdrew a net $16.6B in Q2 2023, closing 1,563 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in BILL Holdings worth $222M.

  • Citadel Advisors's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
  • Citadel Advisors added most to Microsoft in Q2 2023, an estimated $640M increase.
  • Citadel Advisors's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
  • Citadel Advisors fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
  • Citadel Advisors's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
  • Citadel Advisors opened 1,205 new positions and closed 1,563 in Q2 2023.
  • Citadel Advisors's portfolio value rose 6.4% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.